{"status":"success","data":{"title":"IV Fluid Formulations for ICU Patients","slug":"iv-fluids-for-icu-patients","tags":null,"collection":["critical care"],"content":"\n# Intravenous Fluid Formulations and Chloride-Restrictive IV Fluids for ICU Patients\n\n|  Content per 1 L    | Lactated Ringer's |  Normal Saline (0.9%) | Plasma-Lyte 148 |  D5W  | D5 1/2NS  | 5% albumin      |\n|---------------------|-------------------|-----------------------|-----------------|-------|-----------|-----------------|\n| Na (mEq)            | 130               | 154                   | 140             |       | 77        | 130-160         |\n| K (mEq)             | 4                 |                       | 5               |       |           | &lt; 1          |\n| Cl (mEq)            | 109               | 154                   | 98              |       | 77        | 130-160         |\n| Ca (mEq)            | 3                 |                       |                 |       |           |                 |\n| Mg (mEq)            |                   |                       | 3               |       |           |                 |\n| Lactate (mEq)       | 28                |                       |                 |       |           |                 |\n| Acetate (mEq        |                   |                       | 27              |       |           |                 |\n| Gluconate (mEq)     |                   |                       | 23              |       |           |                 |\n| Glucose (mg/dL)     |                   |                       |                 | 4545  | 4545      |                 |\n| Osmolarity (mOsm/L) | 273               | 308                   | 294             | 252   | 406       | 309             |\n| pH                  | 6.5               | 5.0                   | 5.0             | 4.0   | 4.5       | 6.4-7.4         |\n| Other               |                   |                       |                 |       |           | 50 g/L  albumin |\n\n[Yunos et al JAMA 2012 study:](https://www.ncbi.nlm.nih.gov/pubmed/?term=23073953)\n\n-   Prospective open, label sequential study of 760 ICU patients (control) and 773 ICU patients (study group) at single hospital in Melbourne, Australia\n-   Control period: Standard IVF per physician preference\n-   Study period: Chloride-rich IVF (0.9% saline, 4% succinylated gelatin solution, 4% albumin) became restricted and required specialist approval. Standard fluids allowed were chloride-restrictive fluids (Hartmann solution – similar to lactated ringer’s, Plasma-Lyte 148, chloride-poor 20% albumin)\n\n|    |  Control period (Chloride-liberal)  | Study period (Chloride-restricted)   | P value   | Odds ratio for Cl-restrictive  fluid use       |\n|--------|--------------------|------------------------|-----------|----------------|\n| Mean serum Cr increased in umol/L                                            | 22.6 (0.26 mg/dL)        | 14.8 (0.17 mg/dL) | 0.3       |                |\n| Incidence of injury & failure class for \"acute kidney injury\" (RIFLE defn) | 14%                | 8.4%                   | &lt;0.001 | 0.52           |\n| Use of renal replacement therapy (RRT)    | 10%                | 6.3%                   | 0.005     | 0.52           |\n\n**Bottom line:** Chloride-rich IV fluids were associated w/ greater acute kidney injury and need for RRT in ICU patients, compared to chloride-restrictive IV fluids. \n\n**NOTE:** There was, however, NO difference in mortality, hospital, ICU length of stay, or RRT after hospital discharge.\n\n## References\n\n-   [Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012 Oct 17;308(15):1566-72. doi: 10.1001/jama.2012.13356.](https://www.ncbi.nlm.nih.gov/pubmed/?term=23073953)\n-   [http://www.medscape.org/viewarticle/503138](http://www.medscape.org/viewarticle/503138%20)\n"}}